/ Print /

PHARMACY BEST PRACTICES

Patients demand access to investigational therapiesExpanded access or “compassionate use” programs allow patients to use investigational treatments, medical devices, or tests, before they have received FDA approval.
How biomarkers can personalize cancer immunotherapyASCO 2016 presenters share how combination therapies and biomarkers can better identify which tumors are likely to succumb to particular immunotherapies
‘Game changing’ migraine drugs on the horizonThere’s no silver bullet for migraine treatments, but treatments are getting more precise as we learn more about the cause of migraines.
Four critical components for successful, value-based pharma contractsDespite their proliferation, at-risk pharma contracts are still little more than value-based window dressing. Here are four critical components of contracts that can actually move the value meter in the right direction.
New agreement supports value-based pharma contractingIndustry experts are using their proprietary data/analysis to help structure contracts between pharmaceutical companies and plans.
Spike in drug shortages raises alarm
Spike in drug shortages raises alarmDrug shortages take a toll, especially on emergency department patients.
Will price impede recently approved implant for opioid addicts?Probuphine implant could be a new option for addicts if obstacles, such as price, don’t get in the way.
Three ways to maximize value in cancer treatmentAdvancements in treatment show cancer trending towards a chronic condition. Align your cancer chronic care management team now. Here’s how. Advancements in treatment show cancer trending towards a chronic condition. Align your cancer chronic care management team now. Here's how.
Opinion: Top 4 lessons learned from Asembia 2016Insights from the 2016 edition of the largest gathering in specialty pharmacy.
New payer trends for opioids coincide with epidemicA new study examines payer payment shifts for opioids.